Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Immunex completes BLA submission for Enbrel

May 8, 1998

Hydroxamic and carboxylic acid derivatives as inhibitors of MMPs and TNF production

May 8, 1998

Patient enrollment complete for phase III trial of GL-701 in SLE

May 6, 1998

Taisho prepares new cytokine inhibitors for inflammatory, allergic and other disorders

May 5, 1998

Bindarit development redirected toward SLE indication

May 5, 1998

Taisho scientists isolate cell adhesion inhibitors for arthritis, inflammation and asthma

May 1, 1998

Connetics and Suntory sign agreement for scleroderma treatment

April 29, 1998

Merck presents clinical data on COX-2 inhibitor at FASEB 98

April 28, 1998

New findings support the hypothesis that fetal cells are involved in scleroderma

April 28, 1998

Dupuytren's disease treatment shows promise in early clinical trials

April 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...